Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGOG.L Regulatory News (GOG)

  • There is currently no data for GOG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Go-Ahead Group plc

21 Sep 2022 15:20

RNS Number : 1811A
BlackRock Group
21 September 2022
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Go-Ahead Group plc, The

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20 September 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

922,940

2.13%

0

0.00%

(2) Cash-settled derivatives:

 

0

0.00%

379

0.00%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

 

TOTAL:

922,940

2.13%

379

0.00%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Sale

896

GBP 15.4200

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

21 September 2022

Contact name:

Jana Blumenstein

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFLFAIILFIF
Date   Source Headline
20th Jan 202112:46 pmRNSEmployee Benefit Trust Share Purchase
14th Jan 20213:14 pmRNSDirector/PDMR Shareholding
8th Jan 20215:26 pmRNSHolding(s) in Company
4th Jan 20219:00 amRNSBlock listing Interim Review
23rd Dec 20203:42 pmRNSHolding(s) in Company
23rd Dec 20207:00 amRNSHolding(s) in Company
22nd Dec 202011:59 amRNSEmployee Benefit Trust Share Purchase
18th Dec 20205:29 pmRNSDirector/PDMR Shareholding
18th Dec 20202:40 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:00 amRNSGo-Ahead trading update
24th Nov 20204:39 pmRNSResult of AGM
24th Nov 20203:21 pmRNSHolding(s) in Company
20th Nov 20204:31 pmRNSDirector/PDMR Shareholding
20th Nov 20204:12 pmRNSEmployee Benefit Trust Share Purchase
20th Nov 20204:06 pmRNSDirector/PDMR Shareholding
13th Nov 20204:20 pmRNSDirector/PDMR Shareholding
29th Oct 20207:37 amRNSHolding(s) in Company
27th Oct 20204:58 pmRNSHolding(s) in Company
15th Oct 20203:57 pmRNSAnnual Report and Accounts / AGM
13th Oct 20205:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202011:49 amRNSDirector/PDMR Shareholding
24th Sep 20207:00 amRNSGo-Ahead: Full year results 2020
21st Sep 20207:00 amRNSNew GTR contract to run to September 2021
15th Sep 20202:22 pmRNSDirector/PDMR Shareholding
1st Sep 20207:51 amRNSHolding(s) in Company
26th Aug 20207:00 amRNSSingapore bus contract extension
14th Aug 20202:52 pmRNSDirector/PDMR Shareholding
13th Aug 20208:02 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSThe Go-Ahead Group plc - regional bus funding
6th Aug 20207:00 amRNSFull year results date change
14th Jul 20201:14 pmRNSDirector/PDMR Shareholding
8th Jul 20209:34 amRNSHolding(s) in Company
1st Jul 202010:33 amRNSBlock listing Interim Review
15th Jun 20205:01 pmRNSDirector/PDMR Shareholding
29th May 20205:08 pmRNSHolding(s) in Company
22nd May 20207:00 amRNSTrading Statement
13th May 20202:47 pmRNSDirector/PDMR Shareholding
28th Apr 20204:10 pmRNSDisclosure of rights attached to equity shares
22nd Apr 202012:01 pmRNSHolding(s) in Company
21st Apr 20204:01 pmRNSDirector/PDMR Shareholding
20th Apr 20207:00 amRNSEmployee Benefit Trust Share Purchase
15th Apr 20203:45 pmRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSRegional Bus Funding
31st Mar 20207:12 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSSoutheastern Direct Award Contract
23rd Mar 20207:04 amRNSStatement on the coronavirus (COVID-19)
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20209:50 amRNSEmployee Benefit Trust Share Purchase
16th Mar 20204:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.